Transcription factor interactions in human lung

Same author

Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps.

Allergy·2026

Same author

Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper.

Allergy·2026

Same author

The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways-An EAACI Position Paper.

Allergy·2026

Same author

Observation of B_{c}^{+}→Dh^{+}h^{-} Decays.

Physical review letters·2026

Same author

First Observation of the Charmless Baryonic Decay B^{+}→Λ[over ¯]pp[over ¯]p.

Physical review letters·2026

Same author

Observation of Orbitally Excited B_{c}^{+} States.

Physical review letters·2025

Same journal

TDP-43 proteinopathy as a biomarker and therapeutic target in amyotrophic lateral sclerosis.

Biochemical Society transactions·2026

Same journal

Advancing the monitoring of organelle contact sites in vitro and in vivo.

Biochemical Society transactions·2026

Same journal

Mechanisms influencing transient cytoplasmic protein targeting to intracellular lipid droplets.

Biochemical Society transactions·2026

Same journal

Replication associated nuclear DNA mismatch repair across kingdoms.

Biochemical Society transactions·2026

Same journal

Phosphatases of regenerating liver downregulate PTEN to promote tumorigenesis.

Biochemical Society transactions·2026

Same journal

Implications of Rho GTPase signaling in cancer immunotherapy.

Biochemical Society transactions·2026

Related Experiment Videos

Transcription factor interactions in human lung

Related Concept Videos

Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps.

Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper.

The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways-An EAACI Position Paper.

Observation of B_{c}^{+}→Dh^{+}h^{-} Decays.

First Observation of the Charmless Baryonic Decay B^{+}→Λ[over ¯]pp[over ¯]p.

Observation of Orbitally Excited B_{c}^{+} States.

TDP-43 proteinopathy as a biomarker and therapeutic target in amyotrophic lateral sclerosis.

Advancing the monitoring of organelle contact sites in vitro and in vivo.

Mechanisms influencing transient cytoplasmic protein targeting to intracellular lipid droplets.

Replication associated nuclear DNA mismatch repair across kingdoms.

Phosphatases of regenerating liver downregulate PTEN to promote tumorigenesis.

Implications of Rho GTPase signaling in cancer immunotherapy.

Related Experiment Videos

Transcription factor interactions in human lung

Related Concept Videos

Related Articles

Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps.

Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper.

The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways-An EAACI Position Paper.

Observation of B_{c}^{+}→Dh^{+}h^{-} Decays.

First Observation of the Charmless Baryonic Decay B^{+}→Λ[over ¯]pp[over ¯]p.

Observation of Orbitally Excited B_{c}^{+} States.

TDP-43 proteinopathy as a biomarker and therapeutic target in amyotrophic lateral sclerosis.

Advancing the monitoring of organelle contact sites in vitro and in vivo.

Mechanisms influencing transient cytoplasmic protein targeting to intracellular lipid droplets.

Replication associated nuclear DNA mismatch repair across kingdoms.

Phosphatases of regenerating liver downregulate PTEN to promote tumorigenesis.

Implications of Rho GTPase signaling in cancer immunotherapy.